CCAP Q1 2026 Earnings Narrow EPS Miss Highlights Steady Portfolio Returns UDR Q1 2026 Earnings Massive EPS Beat of 413 Surprises Analysts Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase CVNA Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher